BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Diagnosis
16 results:

  • 1. Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive diagnosis of pancreatic Solid Lesions.
    Cho JH; Kim J; Lee HS; Ryu SJ; Jang SI; Kim EJ; Kang H; Lee SS; Song TJ; Bang S
    Gut Liver; 2024 Jan; 18(1):184-191. PubMed ID: 37317559
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer.
    Gu Y; Hua Q; Li Z; Zhang X; Lou C; Zhang Y; Wang W; Cai P; Zhao J
    BMC Cancer; 2023 Mar; 23(1):227. PubMed ID: 36899319
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer survival in the northwestern of São Paulo State, Brazil: A population-based study.
    Mafra A; Bardot A; Charvat H; Weiderpass E; Soerjomataram I; Fregnani JHTG
    Cancer Epidemiol; 2023 Apr; 83():102339. PubMed ID: 36863216
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of pancreatic Ductal Adenocarcinoma.
    He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
    Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Performance of SPINK1 and SPINK1-based diagnostic model in detection of hepatocellular carcinoma.
    Wang F; Liu H; Bai Y; Li H; Wang Z; Xu X
    J Clin Lab Anal; 2021 Nov; 35(11):e24025. PubMed ID: 34569662
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
    JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Assessment of Modifiable Factors for the Association of Marital Status With cancer-Specific Survival.
    Chen ZH; Yang KB; Zhang YZ; Wu CF; Wen DW; Lv JW; Zhu GL; Du XJ; Chen L; Zhou GQ; Liu Q; Sun Y; Ma J; Xu C; Lin L
    JAMA Netw Open; 2021 May; 4(5):e2111813. PubMed ID: 34047792
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic pancreatic Adenocarcinoma.
    Botrus G; Kosirorek H; Sonbol MB; Kusne Y; Uson Junior PLS; Borad MJ; Ahn DH; Kasi PM; Drusbosky LM; Dada H; Surapaneni PK; Starr J; Ritter A; McMillan J; Wylie N; Mody K; Bekaii-Saab TS
    Oncologist; 2021 Jul; 26(7):569-578. PubMed ID: 33555095
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Magnetic Resonance Imaging May Be Able to Identify the Origin of Neuroendocrine Tumor Liver Metastases.
    Barat M; Soyer P; Al Sharhan F; Terris B; Oudjit A; Gaujoux S; Coriat R; Hoeffel C; Dohan A
    Neuroendocrinology; 2021; 111(11):1099-1110. PubMed ID: 33190136
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer.
    Zhang J; Wang Y; Zhao T; Li Y; Tian L; Zhao J; Zhang J
    World J Surg Oncol; 2020 Feb; 18(1):31. PubMed ID: 32028958
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
    Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Amylase concentration in drainage fluid as a predictive factor for severe postoperative pancreatic fistula in patients with gastric cancer.
    Taniguchi Y; Kurokawa Y; Mikami J; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Surg Today; 2017 Nov; 47(11):1378-1383. PubMed ID: 28365893
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling.
    Guo X; Lv X; Fang C; Lv X; Wang F; Wang D; Zhao J; Ma Y; Xue Y; Bai Q; Yao X; Chen Y
    Int J Cancer; 2016 Oct; 139(8):1821-9. PubMed ID: 27281120
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel role of the tumor size in pancreatic cancer as an ancillary factor for predicting resectability.
    Chiang KC; Lee CH; Yeh CN; Ueng SH; Hsu JT; Yeh TS; Jan YY; Hwang TL; Chen MF
    J Cancer Res Ther; 2014; 10(1):142-6. PubMed ID: 24762501
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.
    Dimitriadis E; Kalogeropoulos T; Velaeti S; Sotiriou S; Vassiliou E; Fasoulis L; Klapsas V; Synesiou M; Apostolaki A; Trangas T; Pandis N
    Anticancer Res; 2013 Jan; 33(1):191-7. PubMed ID: 23267145
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study.
    Săftoiu A; Vilmann P; Gorunescu F; Janssen J; Hocke M; Larsen M; Iglesias-Garcia J; Arcidiacono P; Will U; Giovannini M; Dietrich C; Havre R; Gheorghe C; McKay C; Gheonea DI; Ciurea T;
    Endoscopy; 2011 Jul; 43(7):596-603. PubMed ID: 21437851
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.